000 01531 a2200421 4500
005 20250518093011.0
264 0 _c20211026
008 202110s 0 0 eng d
022 _a1099-1352
024 7 _a10.1002/jmr.2842
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKöprülüoğlu, Cemal
245 0 0 _aOptimization of norbornyl-based carbocyclic nucleoside analogs as cyclin-dependent kinase 2 inhibitors.
_h[electronic resource]
260 _bJournal of molecular recognition : JMR
_c08 2020
300 _ae2842 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCyclin-Dependent Kinase 2
_xantagonists & inhibitors
650 0 4 _aMolecular Docking Simulation
650 0 4 _aNorbornanes
_xpharmacology
650 0 4 _aNucleosides
_xanalogs & derivatives
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aStructure-Activity Relationship
700 1 _aDejmek, Milan
700 1 _aŠála, Michal
700 1 _aAjani, Haresh
700 1 _aHřebabecký, Hubert
700 1 _aFanfrlík, Jindřich
700 1 _aJorda, Radek
700 1 _aDračínský, Martin
700 1 _aProcházková, Eliška
700 1 _aŠácha, Pavel
700 1 _aKryštof, Vladimír
700 1 _aHobza, Pavel
700 1 _aLepšík, Martin
700 1 _aNencka, Radim
773 0 _tJournal of molecular recognition : JMR
_gvol. 33
_gno. 8
_gp. e2842
856 4 0 _uhttps://doi.org/10.1002/jmr.2842
_zAvailable from publisher's website
999 _c30780305
_d30780305